Neoadjuvant Immunochemotherapy for LAOSCC
Conditions: Oral Squamous Cell Carcinoma; Locally Advanced Head and Neck Carcinoma Interventions: Drug: albumin paclitaxel, cispatin, tirellizumab Sponsors: Lai-ping Zhong; Sun Yat-sen University; Fudan University; Central South University; Fujian Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Neoadjuvant Therapy | Oral Cancer | Research | Skin Cancer | Squamous Cell Carcinoma